Evaluation of Heparin as a potentially interfering substance [Bioanalytics]

posted by Monic  – India, 2019-09-11 14:04 (451 d 09:39 ago) – Posting: # 20584
Views: 1,954

(edited by Monic on 2019-09-11 14:16)

Hi everyone,

Is it required to evaluate the interaction of "heparin" with your analyte of interest during concomitant medication effect as a part of bio-analytical method validation parameter?
since heparin is infused during blood collection to prevent formation of blood clots in clinical phase.

Note: The anticoagulant used for the blood collection in vacutainer is K2EDTA.


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

 Admin contact
21,243 posts in 4,431 threads, 1,483 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Saturday 22:44 CET (Europe/Vienna)

I believe there is no philosophical high-road in science,
with epistemological signposts. No, we are in a jungle
and find our way by trial and error,
building our road behind us as we proceed.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz